ArticleDepression and anxiety2026
Development and External Validation of a Prediction Model to Identify Suicide Attempters in Treatment-Naive Adolescents With Major Depressive Disorder.
Article in Depression and anxiety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Suicidal behavior in adolescents poses a significant risk, and suicide attempts are the strongest predictors of suicide death. Patients with Major Depressive Disorder (MDD) are at high risk of attempting suicide. However, there is still a lack of effective tools in clinical settings to identify these suicide attempters. Methods: The study assessed suicidal attempts and their predictive factors in adolescents first diagnosed with MDD from August 1, 2022, to May 31, 2024. Five algorithms were used for model construction: logistic regression, random forest, decision tree, support vector machine, and XGBoost. Finally, we evaluated the performance of the best model using an independent external validation set. Results: The study included 820 untreated adolescent first-visit MDD patients (618 females [75.4%], average age 14.67 ± 1.69 years). Of these, 481 (58.7%) had disclosed suicidal ideation to others, and 299 (36.5%) reported having attempted suicide. Predictive variables for the outcome included age, grade, BMI z-score, levels of depression and anxiety, sleep quality, history of being left behind, father's occupation, primary residence before age 16, history of non-suicidal self-injury (NSSI) within the last year, and history of disclosure of suicidal ideation. The XGBoost model showed the highest prediction accuracy (ROC_AUC, 0.72; PR_AUC, 0.65) and sensitivity (0.85) after external validation. The history of NSSI within the last year had the strongest predictive effect on suicide attempts, followed by disclosure of suicidal ideation, sleep quality, BMI z-score, and anxiety levels. Conclusions: Despite including only 11 easily collectible clinical variables, the XGBoost model effectively identifies suicide attempters among untreated adolescent first-visit MDD patients and performs stably in external validation sets. This is beneficial for clinicians to conduct evidence-based suicide prevention efforts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.